c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes

WJ Gullick(Hammersmith Hospital), Sharon Love, C Wright(Hammersmith Hospital), DM Barnes, B.A. Gusterson, Adrian L. Harris, DG Altman
British Journal of Cancer
March 1, 1991
10.1038/bjc.1991.100
Cited by 329Open Access
Full Text

Abstract

Related Papers

Studies of the HER-2/ <i>neu</i> Proto-Oncogene in Human Breast and Ovarian Cancer
Dennis J. Slamon, William Godolphin, Lovell A. Jones et al.|Science|1989|6.8k
The Protein Kinase Family: Conserved Features and Deduced Phylogeny of the Catalytic Domains
Steven K. Hanks, Anne Marie Quinn, Tony Hunter|Science|1988|5.1k
Histological Grading and Prognosis in Breast Cancer
H. J. G. Bloom, W Richardson|British Journal of Cancer|1957|2.9k
Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene
William J. Muller, Eric Sinn, Paul K. Pattengale et al.|Cell|1988|1.2k
Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer.
C Wright, Brian Angus, S Nicholson et al.|PubMed|1989|587